Zobrazeno 1 - 10
of 11
pro vyhledávání: '"G. E. Padbury"'
Autor:
Gordon L. Bundy, Harvey Irving Skulnick, L. N. Toth, Johnson Paul D, Theresa M. Schwartz, Paul K. Tomich, Strohbach Joseph Walter, J. C. Lynn, Thomas J. Raub, G. E. Padbury, R. R. Hinshaw, Kong Teck Chong, Suvit Thaisrivongs
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 7:399-402
The sulfonamide substituted pyranones ( 1 ) have recently been shown to be potent HIV protease inhibitors. We prepared a series of sulfone substituted analogs and compared their biological activities to those of the corresponding sulfonamide analogs.
Autor:
Schwartz Tm, G L Bundy, K A Koeplinger, J. K. Mayo, G. E. Padbury, Zhiyang Zhao, Harbach Pr, Zimmermann Dc, C.S. Aaron, M J Hauer, L S Banitt
Publikováno v:
Chemical Research in Toxicology. 9:1230-1239
U-89843 is a novel pyrrolo[2,3-d]pyrimidine antioxidant with prophylactic activity in animal models of lung inflammation. During preclinical safety evaluation, U-89843 was found to give a positive response in the in vitro unscheduled DNA synthesis (U
Autor:
G. E. Padbury, P. G. Larson, C. S. Aaron, L. S. Banitt, K. L. Linseman, J. K. Mayo, J. E. Chin, P. A. Yonkers, Heidi M. Scherch, E. D. Hall, Stephen A. Mizsak, K. L. Belonga, Gordon L. Bundy, J. M. Lin, F. F. Sun, J. M. Tustin, I. M. Richards, Donald E. Ayer, John R. Palmer
Publikováno v:
ChemInform. 27
Autor:
Johnson Paul D, Gordon L. Bundy, Theresa M. Schwartz, Harvey Irving Skulnick, Thomas J. Raub, G. E. Padbury, L. N. Toth, Paul K. Tomich, Strohbach Joseph Walter, J. C. Lynn, Kong Teck Chong, Suvit Thaisrivongs, R. R. Hinshaw
Publikováno v:
ChemInform. 28
The sulfonamide substituted pyranones ( 1 ) have recently been shown to be potent HIV protease inhibitors. We prepared a series of sulfone substituted analogs and compared their biological activities to those of the corresponding sulfonamide analogs.
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 288(3)
Oxidative stress is considered a cause or propagator of acute and chronic disorders of the central nervous system. Novel 2, 4-diamino-pyrrolo[2,3-d]pyrimidines are potent inhibitors of iron-dependent lipid peroxidation, are cytoprotective in cell cul
Autor:
G E, Padbury, G L, Zipp, F J, Schwende, Z, Zhao, K A, Koeplinger, K T, Chong, T J, Raub, S, Thaisrivongs
Publikováno v:
Pharmaceutical biotechnology. 11
Publikováno v:
Chirality. 10(3)
PNU-103017, 4-Cyano-N-(3-(cyclopropyl(5,6,7,8,9,10-hexahydro-4-hydroxy- 2-oxo-2H-cycloocta(b) pyran-3-yl)methyl)phenyl)-benzenesulfonamide, is a selective HIV aspartyl protease inhibitor under evaluation as a potential oral treatment of Acquired Immu
Autor:
E D, Hall, P K, Andrus, S L, Smith, T J, Fleck, H M, Scherch, B S, Lutzke, G A, Sawada, J S, Althaus, P F, Vonvoigtlander, G E, Padbury, P G, Larson, J R, Palmer, G L, Bundy
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 281(2)
A novel group of antioxidant compounds, the pyrrolopyrimidines, has been discovered recently. Many of these possess significantly improved oral bioavailability (56-70% in rats), increased efficacy and potency in protecting cultured neurons against ir
Autor:
Z, Zhao, K A, Koeplinger, G E, Padbury, M J, Hauer, G L, Bundy, L S, Banitt, T M, Schwartz, D C, Zimmermann, P R, Harbach, J K, Mayo, C S, Aaron
Publikováno v:
Chemical research in toxicology. 9(8)
U-89843 is a novel pyrrolo[2,3-d]pyrimidine antioxidant with prophylactic activity in animal models of lung inflammation. During preclinical safety evaluation, U-89843 was found to give a positive response in the in vitro unscheduled DNA synthesis (U
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 24(2)
The biotransformation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-d]pyrimidine (U-89843) has been studied in rat both in vitro and in vivo. Major metabolites observed by HPLC analysis of rat plasma, liver cytosol, and microsomal incubations